The PCI Center

Filter Your Results

 

News

 

DUTCH PEERS Data Evaluate Newer-Generation DES at 3 Years

April 24, 2017 -- A report assessing the 3-year safety and efficacy of implanting newer-generation Resolute Integrity zotarolimus-eluting stents (ZES; Medtronic) versus P…

Cordis Railway Sheathless Access System Approved in Europe

April 18, 2017 -- Cordis, a Cardinal Health company, received the European CE Mark approval for its new Railway sheathless access system, which is now available in select coun…

Study Evaluates PCI for In-Stent CTO

April 17, 2017 -- Lorenzo Azzalini, MD, et al conducted an investigation of procedural and long-term outcomes of percutaneous coronary intervention (PCI) for in-sten…

FFR-Guided Complete Revascularization Evaluated in Patients With STEMI and Severe Nonculprit Disease

April 17, 2017 -- A substudy of the DANAMI-3 -- PRIMULTI trial demonstrated that fractional flow reserve (FFR)-guided complete revascularization improves the prognosis in…

Choice of Stent Evaluated for PCI of Saphenous Vein Grafts

April 17, 2017 -- An evaluation of the choice of stent for percutaneous coronary intervention (PCI) of saphenous vein grafts (SVGs) was published by Javaid Iqbal, MD, et al in…

Vascular Access Site and Outcomes Studied in PCI Procedures of CTO Patients From British Database

April 17, 2017 -- Tim Kinnaird, MD, et al published findings from a study that used a national percutaneous coronary intervention (PCI) database to assess access-sit…

Intra-Aortic Balloon Pump Counterpulsation: Old Friend or Foe?

Lokien X. van Nunen, MD, PhD

March/April 2017—The hemodynamics and utility of IABP counterpulsation in current practice.

Reva Medical's Fantom Bioresorbable Coronary Scaffold Approved in Europe

April 10, 2017 -- Reva Medical, Inc. announced it has received European CE Mark approval for its Fantom drug-eluting bioresorbable coronary scaffold. Fantom is Reva’s fi…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.